• About Nektar
  • Our Leadership
  • Corporate Giving
  • Locations
  • Contacts
• Pipeline
  • Pipeline Overview
  • Nektar Proprietary Products
  • Nektar Partnered Products
  • Drug Development Platforms
• Partners
  • Nektar Partners
• Investor Relations
  • Press Releases
  • Stock Information
  • Financial Events Calendar
  • Analyst Coverage
  • Annual and Financial Reports
  • Corporate Governance
  • Investor Contacts
  • FAQ
  • Investor Advisory
• Media Room
  • Lead Product Backgrounder
  • Press Releases
  • Press Kit
  • Media Contacts
• Information Center
  • Scientific & Partnering Events
  • Multimedia
  • Library
  • Email Alerts
• Careers
  • Life at Nektar
  • Career Opportunities
  • Recruitment Calendar
  • Summer Internships
  • Benefits
  • Recruiting Information
  • Nektar Employee Foundation

• Pipeline Overview
• Nektar Proprietary Products
• Nektar Partnered Products
  • Approved or Filed Products
    • Cimzia®
    • Mircera™
    • Neulasta®
    • Macugen®
    • DEFINITY® Vial
    • Somavert®
    • PEGASYS®
    • SprayGel™
    • DuraSeal®
    • PEG-INTRON®
  • Pipeline Products
• Drug Development Platforms

By sharing with our partners our research, resources, and, perhaps most significantly, our intellectual property, we have successfully brought to market novel therapies that meet vital medical needs. These innovative products are changing the management and treatment of disease in ways that improve outcomes and enrich patients’ lives.